Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III

The Zika virus (ZIKV), a flavivirus transmitted by Aedes mosquitoes, has emerged as a global public health concern. Pre-existing cross-reactive antibodies against other flaviviruses could modulate immune responses to ZIKV infection by antibody-dependent enhancement, highlighting the importance of un...

Full description

Bibliographic Details
Main Authors: Yanling Wu, Shun Li, Lanying Du, Chunyu Wang, Peng Zou, Binbin Hong, Mengjiao Yuan, Xiaonan Ren, Wanbo Tai, Yu Kong, Chen Zhou, Lu Lu, Xiaohui Zhou, Shibo Jiang, Tianlei Ying
Format: Article
Language:English
Published: Taylor & Francis Group 2017-01-01
Series:Emerging Microbes and Infections
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1038/emi.2017.79
_version_ 1797676933004132352
author Yanling Wu
Shun Li
Lanying Du
Chunyu Wang
Peng Zou
Binbin Hong
Mengjiao Yuan
Xiaonan Ren
Wanbo Tai
Yu Kong
Chen Zhou
Lu Lu
Xiaohui Zhou
Shibo Jiang
Tianlei Ying
author_facet Yanling Wu
Shun Li
Lanying Du
Chunyu Wang
Peng Zou
Binbin Hong
Mengjiao Yuan
Xiaonan Ren
Wanbo Tai
Yu Kong
Chen Zhou
Lu Lu
Xiaohui Zhou
Shibo Jiang
Tianlei Ying
author_sort Yanling Wu
collection DOAJ
description The Zika virus (ZIKV), a flavivirus transmitted by Aedes mosquitoes, has emerged as a global public health concern. Pre-existing cross-reactive antibodies against other flaviviruses could modulate immune responses to ZIKV infection by antibody-dependent enhancement, highlighting the importance of understanding the immunogenicity of the ZIKV envelope protein. In this study, we identified a panel of human monoclonal antibodies (mAbs) that target domain III (DIII) of the ZIKV envelope protein from a very large phage-display naive antibody library. These germline-like antibodies, sharing 98%–100% hoLogy with their corresponding germline IGHV genes, bound ZIKV DIII specifically with high affinities. One mAb, m301, broadly neutralized the currently circulating ZIKV strains and showed a synergistic effect with another mAb, m302, in neutralizing ZIKV in vitro and in a mouse model of ZIKV infection. Interestingly, epitope mapping and competitive binding studies suggest that m301 and m302 bind adjacent regions of the DIII C–C′ loop, which represents a recently identified cryptic epitope that is intermittently exposed in an uncharacterized virus conformation. This study extended our understanding of antigenic epitopes of ZIKV antibodies and has direct implications for the design of ZIKV vaccines.Emerging Microbes & Infections (2017) 6, e89; doi:10.1038/emi.2017.79; published online 11 October 2017
first_indexed 2024-03-11T22:37:36Z
format Article
id doaj.art-1b21717166d24c6086f59d7d20833335
institution Directory Open Access Journal
issn 2222-1751
language English
last_indexed 2024-03-11T22:37:36Z
publishDate 2017-01-01
publisher Taylor & Francis Group
record_format Article
series Emerging Microbes and Infections
spelling doaj.art-1b21717166d24c6086f59d7d208333352023-09-22T12:08:35ZengTaylor & Francis GroupEmerging Microbes and Infections2222-17512017-01-016111110.1038/emi.2017.79Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain IIIYanling Wu0Shun Li1Lanying Du2Chunyu Wang3Peng Zou4Binbin Hong5Mengjiao Yuan6Xiaonan Ren7Wanbo Tai8Yu Kong9Chen Zhou10Lu Lu11Xiaohui Zhou12Shibo Jiang13Tianlei Ying14Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical SciencesFudan University, Shanghai 200032, ChinaShanghai Public Health Clinical CenterFudan University, Shanghai 201508, ChinaLindsley F Kimball Research Institute, New York Blood Center, New York, NY 10065, USAKey Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical SciencesFudan University, Shanghai 200032, ChinaShanghai Public Health Clinical CenterFudan University, Shanghai 201508, ChinaKey Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical SciencesFudan University, Shanghai 200032, ChinaShanghai Public Health Clinical CenterFudan University, Shanghai 201508, ChinaShanghai Public Health Clinical CenterFudan University, Shanghai 201508, ChinaLindsley F Kimball Research Institute, New York Blood Center, New York, NY 10065, USAKey Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical SciencesFudan University, Shanghai 200032, ChinaBiomissile Corporation, Shanghai 201203, ChinaKey Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical SciencesFudan University, Shanghai 200032, ChinaShanghai Public Health Clinical CenterFudan University, Shanghai 201508, ChinaKey Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical SciencesFudan University, Shanghai 200032, ChinaKey Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical SciencesFudan University, Shanghai 200032, ChinaThe Zika virus (ZIKV), a flavivirus transmitted by Aedes mosquitoes, has emerged as a global public health concern. Pre-existing cross-reactive antibodies against other flaviviruses could modulate immune responses to ZIKV infection by antibody-dependent enhancement, highlighting the importance of understanding the immunogenicity of the ZIKV envelope protein. In this study, we identified a panel of human monoclonal antibodies (mAbs) that target domain III (DIII) of the ZIKV envelope protein from a very large phage-display naive antibody library. These germline-like antibodies, sharing 98%–100% hoLogy with their corresponding germline IGHV genes, bound ZIKV DIII specifically with high affinities. One mAb, m301, broadly neutralized the currently circulating ZIKV strains and showed a synergistic effect with another mAb, m302, in neutralizing ZIKV in vitro and in a mouse model of ZIKV infection. Interestingly, epitope mapping and competitive binding studies suggest that m301 and m302 bind adjacent regions of the DIII C–C′ loop, which represents a recently identified cryptic epitope that is intermittently exposed in an uncharacterized virus conformation. This study extended our understanding of antigenic epitopes of ZIKV antibodies and has direct implications for the design of ZIKV vaccines.Emerging Microbes & Infections (2017) 6, e89; doi:10.1038/emi.2017.79; published online 11 October 2017https://www.tandfonline.com/doi/10.1038/emi.2017.79cryptic epitopehuman monoclonal antibodiesZika virus
spellingShingle Yanling Wu
Shun Li
Lanying Du
Chunyu Wang
Peng Zou
Binbin Hong
Mengjiao Yuan
Xiaonan Ren
Wanbo Tai
Yu Kong
Chen Zhou
Lu Lu
Xiaohui Zhou
Shibo Jiang
Tianlei Ying
Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III
Emerging Microbes and Infections
cryptic epitope
human monoclonal antibodies
Zika virus
title Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III
title_full Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III
title_fullStr Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III
title_full_unstemmed Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III
title_short Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III
title_sort neutralization of zika virus by germline like human monoclonal antibodies targeting cryptic epitopes on envelope domain iii
topic cryptic epitope
human monoclonal antibodies
Zika virus
url https://www.tandfonline.com/doi/10.1038/emi.2017.79
work_keys_str_mv AT yanlingwu neutralizationofzikavirusbygermlinelikehumanmonoclonalantibodiestargetingcrypticepitopesonenvelopedomainiii
AT shunli neutralizationofzikavirusbygermlinelikehumanmonoclonalantibodiestargetingcrypticepitopesonenvelopedomainiii
AT lanyingdu neutralizationofzikavirusbygermlinelikehumanmonoclonalantibodiestargetingcrypticepitopesonenvelopedomainiii
AT chunyuwang neutralizationofzikavirusbygermlinelikehumanmonoclonalantibodiestargetingcrypticepitopesonenvelopedomainiii
AT pengzou neutralizationofzikavirusbygermlinelikehumanmonoclonalantibodiestargetingcrypticepitopesonenvelopedomainiii
AT binbinhong neutralizationofzikavirusbygermlinelikehumanmonoclonalantibodiestargetingcrypticepitopesonenvelopedomainiii
AT mengjiaoyuan neutralizationofzikavirusbygermlinelikehumanmonoclonalantibodiestargetingcrypticepitopesonenvelopedomainiii
AT xiaonanren neutralizationofzikavirusbygermlinelikehumanmonoclonalantibodiestargetingcrypticepitopesonenvelopedomainiii
AT wanbotai neutralizationofzikavirusbygermlinelikehumanmonoclonalantibodiestargetingcrypticepitopesonenvelopedomainiii
AT yukong neutralizationofzikavirusbygermlinelikehumanmonoclonalantibodiestargetingcrypticepitopesonenvelopedomainiii
AT chenzhou neutralizationofzikavirusbygermlinelikehumanmonoclonalantibodiestargetingcrypticepitopesonenvelopedomainiii
AT lulu neutralizationofzikavirusbygermlinelikehumanmonoclonalantibodiestargetingcrypticepitopesonenvelopedomainiii
AT xiaohuizhou neutralizationofzikavirusbygermlinelikehumanmonoclonalantibodiestargetingcrypticepitopesonenvelopedomainiii
AT shibojiang neutralizationofzikavirusbygermlinelikehumanmonoclonalantibodiestargetingcrypticepitopesonenvelopedomainiii
AT tianleiying neutralizationofzikavirusbygermlinelikehumanmonoclonalantibodiestargetingcrypticepitopesonenvelopedomainiii